Trump 2.0 Overhauls HHS and NIH Advisory Committees, Weakening Vaccine Recommendations

• Susie Wiles, White House chief of staff for President Donald Trump, announced on Monday her diagnosis of early-stage breast cancer, caught early with no plans for leave. • She will undergo several weeks of treatment in Washington, D.C., while remaining full-time at the White House. • President Trump stated, 'She will soon be better than ever!' highlighting her continued role amid health challenges.

• Researchers from Carnegie Mellon and Northwestern Universities conclude insurer consolidation boosts health insurance premiums in US markets. • About 238 million Americans, or 78% of those insured, rely on private health insurance, increasingly concentrated with examples in Medicare Advantage drawing antitrust attention. • The analysis urges regulation and oversight to address market imperfections from asymmetric information and market power.

• A federal judge on Monday blocked HHS from implementing vaccine policy changes made by RFK Jr.'s revamped CDC Advisory Committee on Immunization Practices (ACIP), reversing all recent decisions. • The ruling leaves unresolved the status of the RSV vaccine for infants, potentially making it no longer free for children who need it, as its inclusion was authorized by the current advisers. • Public health experts are scrambling to understand ramifications, with health groups concerned about unintended harms and weakened vaccination recommendations for hepatitis B and COVID-19.

• Health workers in Massachusetts lobby for bill making assaults on staff felonies, approved by House last November awaiting Senate vote by July 31. • Violence surged post-COVID per surveys; bill mandates hospitals assess risks and implement ongoing safety policies. • "Health care workers don't feel supported," says Cambridge Health Alliance nursing officer; Sen. Joan Lovely optimistic for passage to reduce assaults.

• The FDA on March 13 expanded approval of GSK's Arexvy RSV vaccine to adults aged 18-49 at increased risk of lower respiratory tract disease. • Phase 3b trial data showed non-inferior immune response in younger adults compared to those 60+, targeting 21 million U.S. adults under 50 with conditions like diabetes or obesity. • RSV causes 17,000 hospitalizations, 277,000 emergency visits, and 2 million outpatient visits yearly in this group, highlighting need for broader protection amid rising cases.

• The FDA linked Raw Farm's raw cheddar cheese to seven E. coli O157:H7 cases across multiple states, a strain causing severe kidney issues, hospitalization, or death. • Producer declined recall of two products despite Sunday's FDA alert on March 16. • Outbreak underscores risks of raw milk products, prompting public warnings to avoid consumption.

• Federal grant funding for FQHCs stayed flat from 2019-2023 while health care costs rose over 25%, leading to negative margins of 2.1% by 2024. • An estimated 11.8 million Americans will lose Medicaid coverage due to $344 billion cuts over the next decade, overwhelming FQHCs with uninsured patients. • Recent closures include a New Hampshire rural site in 2025 and six South Carolina locations last year due to shortfalls.

• The NYC Health Department issued an advisory confirming the first severe mpox clade I case in a city resident, marking the initial detection of this more virulent strain in New York. • Mpox clade I is one of two main genetic groups of the virus, known for causing more severe illness compared to clade II. • This development raises concerns for public health monitoring and response in urban areas amid ongoing global mpox transmission risks.

• 128 Democratic members of Congress urged HHS Secretary Robert F. Kennedy Jr. to extend Title X funding for reproductive health clinics facing a shortfall by March 31. • Grant applications opened late on Friday with a one-week deadline, described as 'laughable' by recipients expecting months-long processes. • The delay risks clinic closures, cutting access to birth control, STI testing, and treatment for millions.

• On March 13, 2026, the EPA proposed repealing a 2024 Biden administration rule limiting ethylene oxide emissions from commercial sterilizer facilities, which sterilize about half of U.S. medical devices like heart valves and pacemakers. • The rule aimed to reduce cancer risks to nearby communities but is criticized for threatening domestic supply chains and relying on flawed risk models, per the Trump administration. • Ethylene oxide debate pits public health protections against medical supply reliability, with evidence suggesting alternative risk assessments like Texas models better match human data.

• A federal judge in Boston on March 16, 2026, temporarily blocked U.S. health officials from reducing the number of universally recommended childhood vaccines, halting changes announced by HHS Secretary Robert F. Kennedy Jr. in January. • The ruling stems from a lawsuit by the American Academy of Pediatrics and other groups challenging cuts to flu, rotavirus, hepatitis A and B, meningitis, and RSV vaccines, with ACIP meetings postponed as a result. • Medical organizations hailed the decision as restoring science-based policy, while HHS spokesman Andrew Nixon stated 'HHS looks forward to this judge’s decision being overturned,' amid concerns over confusion and weakened protections in 30 states.